Drug adverse event reports (FAERS)

Upper gastrointestinal haemorrhage, Dizziness, Asthenia

Drugs: BRILINTA, ASPIRIN

SeriousHospitalizationReport 27325220
Safetyreportversion
1
Safetyreportid
27325220
Primarysourcecountry
CN
Occurcountry
CN
Transmissiondateformat
102
Transmissiondate
20261010
Reporttype
1
Serious
1
Seriousnessdeath
2
Seriousnesslifethreatening
2
Seriousnesshospitalization
1
Seriousnessdisabling
2
Seriousnesscongenitalanomali
2
Seriousnessother
2
Receivedateformat
102
Receivedate
20260930
Receiptdateformat
102
Receiptdate
20260930
Fulfillexpeditecriteria
1
Companynumb
CN-ASTRAZENECA-202609CHN023069CN
Duplicate
1
Reportduplicate
Duplicatesource
NMPACDR
Duplicatenumb
15542055584986562569617
Primarysource
Reportercountry
CN
Qualification
3
Sender
Sendertype
6
Senderorganization
ALEXION PHARMACEUTICALS
Receiver
Receivertype
6
Receiverorganization
FDA
Patient
Patientonsetage
63
Patientonsetageunit
801
Patientagegroup
5
Patientweight
65
Patientsex
1
Reaction
  1. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Upper gastrointestinal haemorrhage
    Reactionoutcome
    2
  2. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Dizziness
    Reactionoutcome
    2
  3. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Asthenia
    Reactionoutcome
    2
Drug
  1. Drugcharacterization
    1
    Medicinalproduct
    BRILINTA
    Drugbatchnumb
    2605118
    Drugauthorizationnumb
    22433
    Drugstructuredosagenumb
    180
    Drugstructuredosageunit
    003
    Drugseparatedosagenumb
    1
    Drugintervaldosageunitnumb
    1
    Drugintervaldosagedefinition
    804
    Drugcumulativedosagenumb
    149760
    Drugcumulativedosageunit
    003
    Drugdosagetext
    180 MILLIGRAM, BID
    Drugadministrationroute
    061
    Drugindication
    Antiplatelet therapy
    Drugstartdateformat
    102
    Drugstartdate
    20250410
    Drugenddateformat
    102
    Drugenddate
    20260530
    Drugtreatmentduration
    416
    Drugtreatmentdurationunit
    804
    Actiondrug
    1
    Drugrecurreadministration
    3
    Drugadditional
    1
    Activesubstance
    Activesubstancename
    TICAGRELOR
    Harmonized identifiers (openFDA)
    Application number
    NDA022433
    Brand name
    BRILINTA
    Generic name
    TICAGRELOR
    Manufacturer name
    AstraZeneca Pharmaceuticals LP
    Product NDC
    0186-0776, 0186-0777
    Product type
    HUMAN PRESCRIPTION DRUG
    Route
    ORAL
    Substance name
    TICAGRELOR
    RxCUI
    1116635, 1116639, 1666332, 1666334
    SPL ID
    a9148b29-a2e9-4222-bf15-b55045ac1fe2
    SPL set ID
    f7b3f443-e83d-4bf2-0e96-023448fed9a8
    Package NDC
    0186-0777-08, 0186-0777-60, 0186-0777-18, 0186-0777-39, 0186-0777-28, 0186-0776-60, 0186-0776-94
    Nui
    N0000182142, N0000008832, N0000182143, N0000182141, N0000185503
    Pharm class epc
    P2Y12 Platelet Inhibitor [EPC]
    Pharm class pe
    Decreased Platelet Aggregation [PE]
    Pharm class moa
    P2Y12 Receptor Antagonists [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    UNII
    GLH0314RVC
  2. Drugcharacterization
    1
    Medicinalproduct
    ASPIRIN
    Drugbatchnumb
    26276720
    Drugstructuredosagenumb
    100
    Drugstructuredosageunit
    003
    Drugseparatedosagenumb
    1
    Drugintervaldosageunitnumb
    1
    Drugintervaldosagedefinition
    804
    Drugcumulativedosagenumb
    41600
    Drugcumulativedosageunit
    003
    Drugdosagetext
    100 MILLIGRAM, QD
    Drugadministrationroute
    061
    Drugindication
    Antiplatelet therapy
    Drugstartdateformat
    102
    Drugstartdate
    20250410
    Drugenddateformat
    102
    Drugenddate
    20260530
    Drugtreatmentduration
    416
    Drugtreatmentdurationunit
    804
    Actiondrug
    1
    Drugrecurreadministration
    3
    Drugadditional
    1
    Activesubstance
    Activesubstancename
    ASPIRIN
    Harmonized identifiers (openFDA)
    Application number
    M013, M013.50, part343, M
    Brand name
    BAYER GENUINE ASPIRIN, ASPIRIN, ADULT LOW DOSE ASPIRIN, DRUG MART EFFERVESCENT PAIN RELIEF, ASPIRIN LOW DOSE, ASPIRIN ENTERIC COATED, ASPIRIN 81, ADULT CHEWABLE ASPIRIN, ASPIRIN 81MG, ADULT LOW DOSE ENTERIC COATED ASPIRIN, ASPIRIN LOW DOSE SAFETY COATED, GERITREX ASPIRIN, BUFFERED ASPIRIN, ENTERIC COATED ASPIRIN, BUFFERIN REGULAR STRENGTH PAIN RELIEF, WISPIRIN, EQUATE ASPIRIN, LOW DOSE ASPIRIN, HEB EFFERVESCENT PAIN RELIEF, PAIN RELIEF ASPIRIN LOW DOSE, ASPIRIN 81 MG LOW DOSE, ASPIRIN EXTRA STRENGTH, BAYER CHEWABLE - ASPIRIN REGIMEN LOW DOSE ASPIRIN CHERRY FLAVORED, TRAVEL SAVVY ASPIRIN, CHEWABLE ASPIRIN 81 MG, TOPCARE ASPIRIN, RAPIDOL ASPIRIN, CAREALL ASPIRIN, ASPIRIN REGULAR STRENGTH, REGULAR STRENGTH ASPIRIN, LOW DOSE MINIPRIN ENTERIC SAFETY COATED, ASPIRIN DELAYED RELEASE, GOOD NEIGHBOR PHARMACY ASPIRIN, CHEWABLE ASPIRIN, LEADER ASPIRIN, CHEWABLE LOW DOSE ASPIRIN, CIRCLE K ASPIRIN 325, LOW DOSE ASPIRIN ENTERIC SAFETY COATED, ASPIRIN 81MG ENTERIC COATED, CHILDRENS ASPIRIN +86 more
    Generic name
    ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG
    Manufacturer name
    Unifirst First Aid Corporation, Health Pharma USA LLC, Topco Associates, LLC, Advanced Rx LLC, Discount Drug Mart Inc, STRATEGIC SOURCING SERVICES LLC, L.N.K. International, Inc., Grocery Outlet, Rising Pharma Holdings, Inc., HARRIS TEETER, BETTER LIVING BRANDS LLC., Bi-Mart, Trifecta Pharmaceuticals USA LLC, Marc Glassman, Inc., Care One (Retail Business Services, LLC.), Geritrex LLC, Cardinal Health 110, LLC. DBA Leader, DISCOUNT DRUG MART, Genomma Lab USA, Wisdrug AG, Wal-Mart Stores Inc, Advance Pharmaceutical Inc., P & L Development, LLC, H. E. BUTT GROCERY COMPANY, Rite Aid Corporation, Richmond Pharmaceuticals, Inc., Magno-Humphries, Inc., CHAIN DRUG MARKETING ASSOCIATION, INC., Time-Cap Labs, Inc, Bayer HealthCare LLC., Allegiant Health, Bellegrove Medical Supply, Inc., Padagis US LLC, United Natural Foods, Inc. dba UNFI, PROSTAT FIRST AID, Walgreen Company, HYVEE INC, Topco Associates LLC, COSTCO WHOLESALE CORPORATION, Geri-Care Pharmaceutical Corp +117 more
    Product NDC
    47682-456, 71679-302, 36800-545, 80513-289, 53943-431, 70677-1121, 50844-600, 85828-372, 57237-302, 72036-252, 21130-428, 37835-571, 69396-173, 68998-146, 72476-263, 54162-940, 70000-0147, 53943-081, 50066-610, 87580-001, 49035-467, 17714-009, 59726-065, 37808-861, 70000-0253, 11822-0600, 54738-128, 54257-274, 83324-090, 49483-382, 0280-2090, 69168-318, 59961-616, 59961-620, 0574-7034, 17714-010, 41163-563, 58228-0071, 0363-0218, 42507-605 +270 more
    Product type
    HUMAN OTC DRUG
    Route
    ORAL, RECTAL
    Substance name
    ASPIRIN
    RxCUI
    211874, 212033, 308416, 2606079, 318272, 198467, 260847, 198471, 825180, 198464, 1052678, 387090, 212086, 794229, 1189781, 243670, 749795, 211832
    SPL ID
    3e5d2e28-1c08-7a10-e063-6294a90a551e, 50385717-c87c-b515-e063-6394a90aa371, 035fcef2-398e-401b-90b2-33cf5b522c04, 38ec4680-85ec-6450-e063-6294a90aeb69, 1c35f394-a222-6531-e063-6394a90acb8a, 24b274d6-f226-07eb-e063-6394a90a1d7d, 62d04705-d057-45a8-b5c3-18c9c82caa65, 2f13f7b8-33e5-4f1d-91f2-d210ed8c72d2, ffa0c51f-1493-4897-99cf-8ae6ab2a6f05, 58debf07-b093-bc03-e063-6294a90a28fa, 2d62fa1e-80f4-1f9e-e063-6394a90a575d, 31151537-fd19-b17e-e063-6394a90aad81, 372be4d6-cde3-c6a2-e063-6294a90a8825, 27d89e9f-7a2e-1bb8-e063-6394a90a4b4e, c1884ada-373c-47d9-8b7f-63b9d9067ac1, cc723205-04c3-410f-8fa1-93900afb9142, d10425d7-6e69-45d3-b91d-c02f5884923d, 249d869c-d17e-ebcb-e063-6394a90a94b6, 4f652a68-82a2-4c22-acc4-2cb28f96b358, 4e70ec5e-d034-a525-e063-6394a90a5a93, 07be5485-529c-4f12-ab56-55296f3691ee, 2a32783c-571f-26cb-e063-6394a90af066, 008ee85b-5cac-45a6-a857-a828f8125175, 285f424d-b50c-c734-e063-6394a90a9680, a5bb5d00-5da7-4488-8683-b4ae43a2125f, 03139c1b-6cee-4d3c-89dd-b07596d75ee7, 5cc44dca-00c9-b589-e053-2a91aa0a0521, 08bf7b4e-4f73-7538-e063-6394a90a6627, 1ac70227-c7c3-de60-e063-6394a90aeed7, 7d3ee158-5996-c9c6-e053-2991aa0a844a, 4526b3d0-3666-afe5-e063-6294a90af3ab, e6eab4fe-e1dc-4b80-9711-d4c74618eb4b, 3e5d63ea-c1b6-f7fc-e063-6394a90ae253, a6ca751c-7438-4a0f-adae-d176f73f4915, 5cc8b5f1-4ae4-471b-e053-2991aa0a84c1, 180c7e2b-b245-43e4-a26d-4e8b083d7a86, 3bdb9dec-858a-3145-e063-6394a90acd0d, e38f2a95-358e-4403-8a80-8598a13f455b, 484bf6d3-b6b3-8d71-e063-6294a90a3e58, f81a8e68-63f5-445f-9d86-b82e04d7a191 +255 more
    SPL set ID
    356e4ff4-a7f1-4a50-9b86-2555e232b300, 503868bb-48e0-b718-e063-6394a90a9c5b, 56c125de-fabf-41fa-88a4-760d2793f202, ad0d6a5c-eee9-406c-8d7f-1df9b45f5340, 1c35f394-a221-6531-e063-6394a90acb8a, 2ca87a29-1f54-4da4-a66f-3b3dd4f0396c, 2f6ec676-3832-420e-be91-fce83f6586c8, 79c64e27-87aa-4081-8cbf-343768b00b90, bfc4fd55-45db-41f4-b878-a6b7155f0849, c6a28617-1769-7a7d-e053-2995a90a1ea0, f300dfbc-7137-79d1-e053-2995a90a636e, 08769966-2f6e-4fce-8391-ec1910ab5e7a, 372be427-acbd-c10c-e063-6294a90a572d, 3d519af3-9398-4439-8253-1e5d4612b8e3, 6659e103-fa03-4de0-af42-d2fbd548a87c, 93fb4359-c93d-46c4-b36e-611b829f514c, e5f68c1a-21f3-45a1-861f-229a95b3721c, 03ed19dd-1cfc-47d5-b83e-ffa2ebe93f48, 3543b2bf-1062-468a-a5dc-eabb2408af8c, 4e70ec5e-d033-a525-e063-6394a90a5a93, ea3f8eed-7b70-4156-9586-125d27bf29a8, f6a9ea44-08b8-4a33-bfbd-68cb2d852c39, 0058175f-3474-40c3-a046-6cfaec86d84b, 03876c71-60ec-3280-e063-6294a90a62dc, 318cc982-23a9-4804-b6fb-248f772d7a38, 503408ed-e799-48a0-8d38-3034f4a0ead5, 6a4c897d-c2a8-41b8-98b7-e7da8e2819ec, a7c02378-4213-4e57-aca2-2437ad02f786, bfb9af64-3195-44bf-bcf3-6b36b40d3cc7, efc7d42a-241a-422d-bc08-be2f5f774b62, 070d5713-e018-2913-e054-00144ff8d46c, 3ca60fa3-0a0c-4b3e-a0a2-da527ccf4fe5, bae80044-ad7f-3bf5-e053-2995a90a42f9, cce244aa-cd79-49c8-b68e-267f2bd0ef67, f2e7332a-bcd6-4aef-9e4c-a2cef5ea9464, 18b79449-5c4c-41ce-9609-80f5efa0375c, 3bdb9d89-9000-69f9-e063-6294a90a0c97, 413b3b95-2867-4534-8290-54f477cccf1e, 459f749f-9d23-8752-e063-6394a90a8c81, 8133c3fc-97ce-46b4-8580-7da9f09f622b +255 more
    Package NDC
    47682-456-50, 47682-456-47, 71679-302-00, 36800-545-60, 80513-289-03, 53943-431-36, 70677-1121-1, 50844-600-32, 50844-600-95, 50844-600-14, 50844-600-01, 50844-600-17, 85828-372-17, 57237-302-12, 57237-302-10, 72036-252-01, 21130-428-12, 21130-428-20, 37835-571-12, 37835-571-05, 69396-173-01, 68998-146-01, 72476-263-12, 72476-263-30, 54162-940-90, 70000-0147-1, 53943-081-02, 50066-610-13, 50066-610-30, 87580-001-01, 49035-467-68, 49035-467-08, 17714-009-36, 59726-065-30, 37808-861-36, 70000-0253-2, 70000-0253-4, 70000-0253-1, 70000-0253-3, 11822-0600-6 +576 more
    Nui
    N0000000160, N0000008836, M0001335, N0000175722, N0000175578, N0000008832
    Pharm class moa
    Cyclooxygenase Inhibitors [MoA]
    Pharm class pe
    Decreased Prostaglandin Production [PE], Decreased Platelet Aggregation [PE]
    Pharm class cs
    Anti-Inflammatory Agents, Non-Steroidal [CS]
    Pharm class epc
    Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
    UNII
    R16CO5Y76E
Summary
Narrativeincludeclinical
CASE EVENT DATE: 20260530
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

How to read this: Each report says someone told FDA an event happened while a product was used. A report does not show the product caused it, and counts rise and fall with how many people report. Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.